Newbridge Financial Services Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.6K | Hold |
839
| – | – | 0.01% | 476 |
|
|
2025
Q1 | $61.6K | Buy |
839
+1
| +0.1% | +$73 | 0.02% | 336 |
|
|
2024
Q4 | $54.9K | Buy |
+838
| New | +$54.9K | 0.01% | 383 |
|
|
2024
Q3 | – | Sell |
-800
| Closed | -$62.4K | – | 694 |
|
|
2024
Q2 | $62.4K | Hold |
800
| – | – | 0.02% | 338 |
|
|
2024
Q1 | $54.2K | Buy |
+800
| New | +$54.2K | 0.02% | 382 |
|
|
2023
Q4 | – | Sell |
-1,456
| Closed | -$98.6K | – | 1161 |
|
|
2023
Q3 | $98.6K | Buy |
1,456
+1
| +0.1% | +$68 | 0.05% | 302 |
|
|
2023
Q2 | $104K | Sell |
1,455
-229
| -14% | -$16.4K | 0.05% | 308 |
|
|
2023
Q1 | $117K | Sell |
1,684
-108
| -6% | -$7.5K | 0.06% | 288 |
|
|
2022
Q4 | $121K | Sell |
1,792
-157
| -8% | -$10.6K | 0.07% | 265 |
|
|
2022
Q3 | $107K | Buy |
1,949
+3
| +0.2% | +$165 | 0.06% | 287 |
|
|
2022
Q2 | $129K | Sell |
1,946
-46
| -2% | -$3.05K | 0.08% | 229 |
|
|
2022
Q1 | $132K | Buy |
1,992
+6
| +0.3% | +$398 | 0.06% | 261 |
|
|
2021
Q4 | $116K | Buy |
1,986
+944
| +91% | +$55.1K | 0.05% | 276 |
|
|
2021
Q3 | $63K | Buy |
1,042
+31
| +3% | +$1.87K | 0.04% | 350 |
|
|
2021
Q2 | $61K | Hold |
1,011
| – | – | 0.04% | 377 |
|
|
2021
Q1 | $50K | Buy |
1,011
+211
| +26% | +$10.4K | 0.04% | 399 |
|
|
2020
Q4 | $40K | Sell |
800
-108
| -12% | -$5.4K | 0.03% | 372 |
|
|
2020
Q3 | $50K | Buy |
+908
| New | +$50K | 0.05% | 317 |
|